Anti-CDC40 antibody [EPR12539],Abcam,AB175924
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Application
ICC/IF, WB, Flow Cyt (Intra), IHC-P
Platform ID
BAB882333272
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Product Specifications
Scientific Background
Specifications
NameAnti-CDC40 antibody [EPR12539]
Cat. No.AB175924
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationICC/IF, WB, Flow Cyt (Intra), IHC-P
ClonalityMonoclonal
Clone NumberEPR12539
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only
Scientific Background
Target data Required for pre-mRNA splicing as component of the activated spliceosome (PubMed : 33220177). Plays an important role in embryonic brain development; this function does not require proline isomerization (PubMed : 33220177). See full target information CDC40
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.